Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-59
Closed -$8.17K 504
2025
Q2
$8.17K Buy
+59
New +$7.97K ﹤0.01% 238
2014
Q2
Sell
-438
Closed -$36K 203
2014
Q1
$36K Sell
438
-75
-15% -$5.96K 0.01% 161
2013
Q4
$43K Buy
513
+75
+17% +$6.09K 0.01% 160
2013
Q3
$34K Sell
438
-1,558
-78% -$116K 0.01% 168
2013
Q2
$133K Buy
+1,996
New +$138K 0.04% 122

Other funds holding HES

Howard Hughes Medical Institute's HES Position: Q3 2025 in Review

Howard Hughes Medical Institute sold out of Hess (HES) in Q3 2025, closing a stake of 59 shares — an estimated $8.17K sold.

Howard Hughes Medical Institute first reported a position in HES in Q2 2013 and held it in 5 quarters. The position peaked at $133K in Q2 2013. 7 funds tracked by Wall St. Rank hold HES as of Q3 2025.

  • Howard Hughes Medical Institute reported no remaining Hess position as of Q3 2025 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 59 Hess shares in Q3 2025, an estimated $8.17K.
  • Howard Hughes Medical Institute first reported a position in Hess in Q2 2013 and held it in 5 quarters.
  • Howard Hughes Medical Institute's Hess position peaked at $133K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held Hess as of Q3 2025.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2025, filed 14 Nov 2025.